Lumentum Holdings Inc.: Form 10-Q for the period ended Apr 2, 2022
Filed with the SEC on May 4, 2022 and accepted by EDGAR at May 4, 2022, 13:29 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-04-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Gross profit | 3 months2022-01-02 to 2022-04-02 | $167.2m | us-gaap:GrossProfit |
| Gross profit | 9 months2021-07-04 to 2022-04-02 | $606.9m | us-gaap:GrossProfit |
| Research and development | 3 months2022-01-02 to 2022-04-02 | $56.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2021-07-04 to 2022-04-02 | $164.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-01-02 to 2022-04-02 | $63.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2021-07-04 to 2022-04-02 | $196.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-01-02 to 2022-04-02 | $46.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-07-04 to 2022-04-02 | $247.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-01-02 to 2022-04-02 | $19.7m | us-gaap:InterestExpense |
| Interest expense | 9 months2021-07-04 to 2022-04-02 | $53.7m | us-gaap:InterestExpense |
| Income tax | 3 months2022-01-02 to 2022-04-02 | $3.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-07-04 to 2022-04-02 | $33.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-02 to 2022-04-02 | $26.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-07-04 to 2022-04-02 | $164.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-02 to 2022-04-02 | $0.35 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2021-07-04 to 2022-04-02 | $2.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-02 to 2022-04-02 | $0.37 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2021-07-04 to 2022-04-02 | $2.28 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-02 to 2022-04-02 | 74,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-07-04 to 2022-04-02 | 75,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-07-04 to 2022-04-02 | $345.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-07-04 to 2022-04-02 | $62.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2021-07-04 to 2022-04-02 | $448.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-04-02 | $1.13bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-04-02 | $3.10bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-04-02 | $4.13bn | us-gaap:Assets |
| Current liabilities | At period end2022-04-02 | $660.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-04-02 | $2.22bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-04-02 | $2.42bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2022-04-02 | $1.91bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-22-012157. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.